Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.215 CAD | -20.37% | +2.38% | +2.38% |
Business Summary
Number of employees: 9
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jacek Antas
CEO | Chief Executive Officer | - | 22-04-17 |
Director of Finance/CFO | 59 | Feb. 13 | |
Chief Tech/Sci/R&D Officer | - | 22-08-31 | |
Chief Tech/Sci/R&D Officer | - | 19-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 22-04-17 | |
Jacek Antas
CEO | Chief Executive Officer | - | 22-04-17 |
Malgorzata Laube
BRD | Director/Board Member | - | 22-12-07 |
Janusz Grabski
BRD | Director/Board Member | - | 23-08-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 245,107,749 | 198,187,874 ( 80.86 %) | 0 | 80.86 % |
Company contact information
Sector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.38% | 38.3M | |
+49.99% | 56.95B | |
+39.98% | 40.26B | |
-6.94% | 39.32B | |
-4.42% | 28.37B | |
+11.88% | 26.45B | |
-18.12% | 19.41B | |
+30.17% | 12.54B | |
+25.29% | 12.21B | |
+0.04% | 12.15B |
- Stock Market
- Equities
- HBP Stock
- Company Helix BioPharma Corp.